They discover that the papilloma test detects cancer of the uterus before

United States

The Human Papillomavirus (HPV) Screening Test identifies precancerous changes in cervical cells of before and after specifically cytology Papanicolaou according to a published clinical study.

The book, published by the journal JAMA, is the work of a team led by Dr. Gina Suzanne Ogilvie, of the Center Health and Women's Hospital in Vancouver, Canada, which for a decade studied data from about 19,000 women.

Research has shown that the human papillomavirus test is more sensitive than Papanicolaou, a widely used test for decades has been the standard procedure to prevent the occurrence of cervical cancer .

HPV is the most common badually transmitted infection in people, whose or the immune system usually clears the virus in one or two years, but when the infection persists, can lead to precancerous lesions or even malignant tumors.

In addition, almost all cases of cervical cancer are due to infections caused by the human papillomavirus.

As experts have learned more about the role of HPV in cervical cancer, there have been more doctors recommending that women be more tested for HPV. less to cytology, a microscopic test of the cells taken by scraping the opening of the cervix of the uterus.

However, according to Ogilvie, instead of throwing Papamicolau, this test must complete the papilloma test.

"The real benefit of the joint trial is with the HPV test," said the researcher also at the University of British Columbia, Vancouver, Canada.

The American Cancer Society c This year, approximately 13,200 new cases of invasive cervical cancer will be diagnosed in the United States and approximately 4,200 women will die from this disease.